Gramine Derivatives Targeting Ca2+ Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases
- 24 June 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 59 (13) , 6265-6280
Abstract
We describe the synthesis of gramine derivatives and their pharmacological evaluation as multipotent drugs for the treatment of Alzheimer’s disease. An innovative multitarget approach is presented, targeting both voltage-gated Ca2+ channels, classically studied for neurodegenerative diseases, and Ser/Thr phosphatases, which have been marginally aimed, even despite their key role in protein τ dephosphorylation. Twenty-five compounds were synthesized, and mostly their neuroprotective profile exceeded that offered by the head compound gramine. In general, these compounds reduced the entry of Ca2+ through VGCC, as measured by Fluo-4/AM and patch clamp techniques, and protected in Ca2+ overload-induced models of neurotoxicity, like glutamate or veratridine exposures. Furthermore, we hypothesize that these compounds decrease τ hyperphosphorylation based on the maintenance of the Ser/Thr phosphatase activity and their neuroprotection against the damage caused by okadaic acid. Hence, we propose this multitarget approach as a new and promising strategy for the treatment of neurodegenerative diseases.Keywords
Funding Information
- Ministerio de Economía y Competitividad (SAF 2013-44108-P)
- Universidad Autónoma de Madrid
- Instituto de Salud Carlos III (PI13/00789)
- Fundación Teófilo Hernando
- Fundación de Investigación Biomédica, Hospital Universitario de La princesa
This publication has 93 references indexed in Scilit:
- Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approachesEuropean Journal of Medicinal Chemistry, 2016
- Tau and neurodegenerative disease: the story so farNature Reviews Neurology, 2015
- The case for rejecting the amyloid cascade hypothesisNature Neuroscience, 2015
- Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer’s DiseaseCurrent Medicinal Chemistry, 2014
- Therapeutics of Alzheimer's disease: Past, present and futureNeuropharmacology, 2014
- The Multifactorial Nature of Alzheimer's Disease for Developing Potential TherapeuticsCurrent Topics in Medicinal Chemistry, 2013
- Sting of Alzheimer's failures offset by upcoming prevention trialsNature Reviews Drug Discovery, 2012
- Tau protein and tau aggregation inhibitorsNeuropharmacology, 2010
- NO-Donating Tacrine Hybrid Compounds Improve Scopolamine-Induced Cognition Impairment and Show Less HepatotoxicityJournal of Medicinal Chemistry, 2008
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer DiseaseCurrent Medicinal Chemistry, 2008